NCT00547274终止3 期
Dyslipidemia in Type 2 Diabetes (0767-034)
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 入组人数
- 111
研究概览
简要总结
The purpose of the study is to compare the lipid-altering effects of MK0767, glipizide, and pioglitazone after 12 weeks of treatment.
This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and non-pregnant females
- •Age greater than or equal to 21 years
- •Stop current diabetes therapy (if applicable)
- •Stop current statin therapy (if applicable)
排除标准
- •History of type 1 diabetes mellitus or ketoacidosis who are currently being treated with insulin
- •Patients on a weight loss program with ongoing weight loss, or starting an intensive exercise program within the last four weeks
- •Patients requiring treatment with corticosteroids for more than 14 consecutive days
- •Patients taking warfarin or warfarin-like anti-coagulants
- •Patients undergoing surgery within 30 days of Visit 1
- •Patients with Hepatitis B, Hepatitis C, active liver or gallbladder disease
- •Patients with history of pancreatitis or uncontrolled high blood pressure
研究者
相似试验
终止
3 期
MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)Diabetes Mellitus, Type 2NCT00543010Merck Sharp & Dohme LLC247
已完成
4 期
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With SchizophreniaCognitive ImpairmentSchizophreniaDiabetesInsulin ResistanceNCT00231894Nathan Kline Institute for Psychiatric Research56
已完成
不适用
Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by NutrientsHealthyNCT01727583Société des Produits Nestlé (SPN)18
尚未招募
3 期
Comparison of lipid profile of patients having diabetes mellitus with hypertension and diabetes mellitus without hypertensioCTRI/2022/07/044140DR vishal anadkat
已完成
3 期
Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With DiabetesType 2 Diabetes MellitusNCT01156597University of Miami30